Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy

European Radiology

Volumn 23, Issue 6, 2013, Pages 1573-1581

  Hwang, Sung Ho ^a   Yoo, Mi Ri ^a   Park, Chul Hwan ^a   Jeon, Tae Joo ^a   Kim, Sang Jin ^a   Kim, Tae Hoon ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

18F fluoro deoxyglucose positron emission tomography; Computed tomography; Enhancement pattern; Non small cell lung cancer; Standardized uptake value

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SIZE; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METABOLISM; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; CONTRAST MEDIA; DRUG THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84878688057     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2755-0     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96
2. Alberg AJ, Ford JG, Samet JM (2007) Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:29S-55S
3. Laskin JJ, Sandler AB (2005) State of the art in therapy for non-small cell lung cancer. Cancer Invest 23:427-442
4. Cooper S, Spiro SG (2006) Small cell lung cancer: treatment review. Respirology 11:241-248
5. Watanabe H, Yamamoto S, Kunitoh H, et al. (2003) Tumor response to chemotherapy: the validity and reproducibility of RECIST guidelines in NSCLC patients. Cancer Sci 94:1015-1020
6. Suzuki C, Jacobsson H, Hatschek T, et al. (2008) Radiologic measurements of tumor response to treatment: practical approaches and limitations. Radiographics 28:329-344
7. Erasmus JJ, Gladish GW, Broemeling L, et al. (2003) Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. J Clin Oncol 21:2574-2582
8. Mazumdar M, Smith A, Schwartz LH (2004) A statistical simulation study finds discordance between WHO criteria and RECIST guideline. J Clin Epidemiol 57:358-365
9. Tran LN, Brown MS, Goldin JG, et al. (2004) Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography. Acad Radiol 11:1355-1360
10. Young H, Baum R, Cremerius U, et al. (1999) Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 35:1773-1782
11. Juweid ME, Cheson BD (2006) Positron-emission tomography and assessment of cancer therapy. N Engl J Med 354:496-507
12. Huang W, Zhou T, Ma L, et al. (2011) Standard uptake value and metabolic tumor volume of (1)F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer. Eur J Nucl Med Mol Imaging 38:1628-1635
13. Cuenod CA, Fournier L, Balvay D, Guinebretiere JM (2006) Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment. Abdom Imaging 31:188-193
14. Schaefer JF, Vollmar J, Schick F, et al. (2004) Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging: perfusion differences in malignant and benign lesions. Radiology 232:544-553
15. Yi CA, Lee KS, Kim EA, et al. (2004) Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density. Radiology 233:191-199
16. Jeong YJ, Lee KS, Jeong SY, et al. (2005) Solitary pulmonary nodule: characterization with combined wash-in and washout features at dynamic multi-detector row CT. Radiology 237:675-683
17. Swensen SJ, Viggiano RW, Midthun DE, et al. (2000) Lung nodule enhancement at CT: multicenter study. Radiology 214:73-80
18. Wang J, Wu N, Cham MD, Song Y (2009) Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy. AJR Am J Roentgenol 193:1090-1096
19. Lind JS, Meijerink MR, Dingemans AM, et al. (2010) Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? Eur Radiol 20:2890-2898
20. Kiessling F, Boese J, Corvinus C, et al. (2004) Perfusion CT in patients with advanced bronchial carcinomas: a novel chance for characterization and treatment monitoring? Eur Radiol 14:1226-1233
21. Pezzella F, Pastorino U, Tagliabue E, et al. (1997) Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 151:1417-1423
22. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324:1-8
23. Valentin J (2000) Avoidance of radiation injuries from medical interventional procedures. Ann ICRP 30:7-67
24. Decoster L, Schallier D, Everaert H, et al. (2008) Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC). Lung Cancer 62:55-61
25. Bellomi M, Petralia G, Sonzogni A, Zampino MG, Rocca A (2007) CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. Radiology 244:486-493
26. Yamashita K, Matsunobe S, Tsuda T, et al. (1995) Solitary pulmonary nodule: preliminary study of evaluation with incremental dynamic CT. Radiology 194:399-405
27. Dean PB, Niemi P, Kivisaari L, Kormano M (1988) Comparative pharmacokinetics of gadolinium DTPA and gadolinium chloride. Invest Radiol 23:S258-S260
28. Patz EF Jr, Connolly J, Herndon J (2000) Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer. AJR Am J Roentgenol 174:769-774